medigraphic.com

2001, Número 1

<< Anterior Siguiente >>

Rev Med Hosp Gen Mex 2001; 64 (1)


Leiomiomatosis difusa del útero. Presentación de un caso y revisión de la literatura

Alcántara VA, Vicuña HI, Hernández GM, González DS, Ramos CR

Idioma: Español
Referencias bibliográficas: 22
Paginas: 27-30
Archivo PDF: 330.95 Kb.


RESUMEN

Se presenta el caso de una mujer de 41 años de edad con crecimiento uterino, debido a la presencia de tumores de estirpe muscular lisa, muchos de ellos microscópicos, y con proliferación de células miógenas alrededor de vasos sanguíneos. Los datos anteriores conforman el cuadro morfológico de leiomiomatosis difusa. Se comenta la patogénesis del padecimiento y el diagnóstico diferencial con sarcoma del estroma endometrial de bajo grado y la adenomiosis.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Clement PB, Young RH. Diffuse leiomyomatosis of the uterus a report of four cases. Int J Gynecol Pathol 1987: 322-330.

  2. Fedele L, Zamber LD, Carinelli S et al., Diffuse uterine leiomyomatosis. Acta Eur Fertil 1982; 13: 125-131.

  3. Mulvany JN, Östör AG, Ross I. Diffuse leiomyomatosis of the uterus. Histopathology 1995; 27: 175-179.

  4. Lai FM, Wong FW, Allen PIV. Diffuse uterine leiomyomatosis with hemorrhage. Arch Pathol Lab Med 1991; 115: 834-837.

  5. Domnitz SW, Roth JA, Corioin LJ. Diffuse leiomyomatosis of the uterus in pregnancy. A case report. J Reprod Med 1994; 39: 61-66.

  6. Clement PB. Intravenous leiomyomatosis of the uterus. Pathol Annu 1988; 2: 153-183.

  7. Murray HL, Glynn E. A case of complete fibromyomatosis of the corpus uteri. J Obstet Gynecol Br Emp 1924; 31: 398-401.

  8. Lapan BS. Diffuse leiomyomatosis of the uterus precloding myomectomy. Obstet Gynecol 1979; 53: 825-845.

  9. Linder G, Garther SM. Glucosa-6-phosphate de hydrogenase mosaicism; utilization as a cell marker in the study of leiomyomas. Science 1965; 2: 3-13.

  10. Nilber TM, Heim S. Uterine leiomyoma cytogenetics. Genes Chrom Cancer 1990; 2: 3-13.

  11. Rem MS, Firedman AJ, Barbieri RL et al. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991; 77: 923-926.

  12. Fayed YM, Tsikris JCM, Langenberg PW et al. Woman uterine leiomyoma cell. Bindig and growth response to epidermal growth factor, platelet-derived growth factor insulin. Lab Invest 1989; 60: 30-37.

  13. Dijke P, Hansen P, Iwata KK et al. Identification of another member of the transforming growth factor type B gene family. Proc Natl Acad Sci USA 1988; 85: 4 715-4 719.

  14. Lumsden MA, West CP, Hawkins RA et al. The binding of steroids to miometrium and leiomyomata (fibroids) in women treated with gonadotrophin-releasing hormone agonist Zoladex (ICI 118630). Endocrinol 1989; 121: 389-396.

  15. Persaud V, Arjoon PD. Uterine leiomyoma; incidence of degenerative change and a correlation of associated symptoms. Obstet Gynecol 1970; 35: 432-436.

  16. Goldzieher JW, Maqueo M, Ricaud L et al. Induction of degenerative changes in uterine myomas by high- dosage progestin the rapy. Am J Obstet Gynecol 1966; 96: 1078-1087.

  17. Myles JL, Hart WR. Apoplectie leiomyomas of the uterus; a clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage. Am J Surg Pathol 1985; 9: 798-805.

  18. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus I: a clinical and pathological Study of 58 endometrial estromal tumors. Cancer 1966; 19: 755-766.

  19. Chang KL, Crabtree GS, Lim-Tan SK et al. Primary uterine endometrial stromal neoplasms. A clinico-pathologic Study of 117 cases. Am J Surg Pathol 1990; 14: 415-438.

  20. Kung R, Lic Kl. Disseminated leiomyomatosis and endometriosis following laparoscopic supracervical hysterectomy. Obstet Gynecol 2000; 95: 35-38.

  21. Gal AA, Brooks JSJ, Pietra GG. Leiomyomatosis neoplasm of the lung a clinical histologic and immunohistochemical. Study Mod Pathol 1989; 2: 209-216.

  22. Allen PW. Benign metastasizing müllerian tumors and uterine sarcomas. Surg Pathol 1990; 3-14.




2020     |     www.medigraphic.com